Obtainment of Monoclonal Antibodies and Prospects of Their Application as Basis for Immunodiagnostic Aids for Crimean-Congo Hemorrhagic Fever Virus Detection

) as framework for the production of tools for CCHF virus detection and identification in artificially contaminated samples and clinical specimens containing CCHF antigens was proven efficient.

вирус Крым-Конго геморрагической лихорадки, моноклональные антитела, коллекция гибридом, депонирование, Crimean-Congo hemorrhagic fever virus, monoclonal antibodies, hybridomas collection, depositing

1. Volynkina A.S., Kotenev E.S., Maletskaya O.V., Zaikina I.N., Shaposhnikova L.I., Kulichenko A.N. [Epidemiological situation on Crimean-Congo hemorrhagic fever in the Russian Federation in 2012 and prognosis for 2013]. Probl. Osobo Opasn. Infek. 2013; 1:30–3.

2. Gaidamovich S.Ya., Mel’nikova E.E, Shutkova T.M., Novokhatsky A.S., Turchinskaya A.L. [Characterization of monoclonal antibodies induced by Crimean hemorrhagic fever virus]. Vopr. Virusol. 1989; 34(2):201–4.

3. Kulichenko A.N., Maletskaya O.V., Vasilenko N.F., Beyer A.P., Sannikova I.V., Pasechnikov V.D., Koval’chuk I.V., Ermakov A.V., Butaev T.M., Smirnova S.E., Karan’ L.S., Maleev V.V., Platonov A.E. [Crimean hemorrhagic fever in Eurasia in the XXI century: epidemiological aspects]. Epidemiol. Infek Bol. Actualn. Vopr. 2012; 3:42–53.

4. Katty D., editor. [Antibodies. Methods]. Vol. 2. M.: Mir; 1991. 384 p.

5. [International Health Regulations (2005)]. 2-nd edition. WHO; 2008. 90 p.

6. Onishchenko G.G., editor. [Specific Indication of Pathogenic Biological Agents. Practical Guidelines]. M.; 2006. 288 p.

7. Onishchenko G.G., Kutyrev V.V., editors. [Laboratory Diagnostics of Dangerous Infectious Diseases. Practical Guidelines]. M.: Meditsina. Shiko; 2009. 472 p.

8. [Order for organizing and conducting laboratory diagnostics of Crimean hemorrhagic fever in the laboratories of territorial, regional, and federal level. Methodological Regulations]. MR 4.2.3007-12. M.; 2012.

9. [Sanitary Protection of the Territory of the Russian Federation]. SR 3.4.2318-08. M.; 2008.

10. Smirnova S.E. [Global area of Crimean-Congo hemorrhagic fever virus]. Byul. Sibir. Meditsiny. 2006; (Appendix 1):79–87.

11. Blackburn N.K., Besselaar T.G., Shepherd A.J., Swanepoel R. Preparation and use of monoclonal antibodies for identifying Crimean-Congo hemorrhagic fever virus. Am. J. Trop. Med. Hyg. 1987; 37(2):392–7.

12. Goding J.W. Monoclonal antibodies: principles and practice. 2nd ed. London: Acad. Press Inc.; 1986. P. 59–103.

13. Liu V., Green A. A. Monoclonal-antibody enzyme immunoassay for detection of hepatitis B surface antigen with use of a biotin-avidin system. Clin. Chemistry. 1985; 31(2):202–5.

14. Marriott A.C., Polyzoni T., Antoniadis A., Nuttall P.A. Detection of human antibodies to Crimean-Congo haemorrhagic fever virus using expressed viral nucleocapsid protein. J. Gen. Virol. 1994; 75:2157–61.

15. Saijo M., Tang Q., Shimayi B., Han L., Zhang Y., Asiguma M., Tianshu D., Maeda A., Kurane I., Morikawa S. Antigen-capture enzymelinked immunosorbent assay for the diagnosis of crimean-congo hemorrhagic fever using a novel monoclonal antibody. J. Med. Virol. 2005; 77(1):83–8.